Industries > Pharma > Biopharmaceuticals Contract Manufacturing Market Report 2020-2030

Biopharmaceuticals Contract Manufacturing Market Report 2020-2030

Forecasts by Service (Process Development (Downstream, Upstream), Fill & Finish Operations, Analytical & Quality Control Studies, Packaging), by Product (Biologics (Monoclonal Antibodies (mAbs), Recombinant Proteins, Vaccines, Insulin), Biosimilars) Plus Analysis of Leading Companies

PUBLISHED: 04 March 2020
PAGES: 179
PRODUCT CODE: PHA0629
SUBMARKET: Contract Services

WOOCS 2.2.1
DOWNLOAD FREE SAMPLE

covid-19

Market Dynamics
• Continuing expansion of biopharmaceutical manufacturing capacity by CDMOs/CMOs
• Increasing outsourcing of biopharmaceuticals-related manufacturing activities
• Increasing demand for fill-finish services in biopharmaceutical contract manufacturing market
• Increasing productivity and efficiency of biopharmaceuticals manufacturing processes
• Uptake of single-use production systems by the biopharmaceutical manufacturing industry
• Asia emerging as hot destination for biopharmaceutical manufacturing
• Increasing confidence of pharmaceutical industry in CDMOs capabilities
• High level of outsourcing of manufacturing newly approved drugs by smaller biotech companies is fueling the growth of biopharma-specific CMOs/CDMOs
• Higher acceptance and success of biopharmaceutical products in the market provides tremendous opportunities to biopharmaceuticals contract manufacturers
• Increasing shortage of skilled workforce in the biopharmaceutical industry
• Expensive manufacturing equipment requirements and complex processes raise barriers to entry, which is limiting market growth
• Complicated and stringent regulatory requirements hinder market growth

Market Segmentation 2020-2030
Biopharmaceuticals Contract Manufacturing Market is segmented on the Service, Product, and Regional basis.

Service

• Process Development
– Downstream
– Upstream

• Fill & Finish Operations
• Analytical & Quality Control Studies
• Packaging

Product

• Biologics
– Monoclonal Antibodies (MAbs)
– Recombinant Proteins
– Vaccines
– Insulin

• Biosimilars

Regional Breakdown
Focused regional forecasts and analysis explore the future opportunities:

Biopharmaceuticals Contract Manufacturing Market Report 2020-2030

• North America
– U.S.
– Canada

• Europe
– UK
– France
– Germany
– Russia
– Rest of Europe

• Asia-Pacific
– China
– Japan
– India
– Southeast Asia
– Rest of Asia Pacific

• Latin America
– Brazil
– Argentina
– Rest of Latin America

• Middle East & Africa
– GCC
– South Africa
– Rest of Middle East

Buy our report today Biopharmaceuticals Contract Manufacturing Market: Forecasts by Service (Process Development (Downstream, Upstream), Fill & Finish Operations, Analytical & Quality Control Studies, Packaging), by Product (Biologics (Monoclonal Antibodies (mAbs), Recombinant Proteins, Vaccines, Insulin), Biosimilars) Plus Analysis of Leading Companies. Avoid missing out by staying informed – order our report now.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Biopharmaceuticals Contract Manufacturing Market Report 2020-2030


Download sample pages

Complete the form below to download your free sample pages for Biopharmaceuticals Contract Manufacturing Market Report 2020-2030


Latest Pharma news

Visiongain Publishes Pharma Wholesale and Distribution Market Report 2022-2032

The pharma wholesale and distribution market was valued at US$511.80 billion in 2021 and is projected to grow at a CAGR of 7.84% during the forecast period 2022-2032.

29 September 2022

READ

Visiongain Publishes Mesenchymal Stem Cells Market Report 2022-2032

The mesenchymal stem cells market was valued at US$2.44 billion in 2021 and is projected to grow at a CAGR of 13.82% during the forecast period 2022-2032.

21 September 2022

READ

Visiongain Publishes Advanced Wound Care Management Market Report 2022-2032

The global advanced wound care management market is estimated to be valued at US$12,581.3 million in 2022. The market is projected to reach a market value of US$23,307.5 million by 2032 and is projected to grow at a CAGR of 6.36% during the forecast period 2022-2032.

16 September 2022

READ

Visiongain Publishes Gene Therapy R&D Market Report 2022-2032

The gene therapy R&D market was valued at US$1,653.0 million in 2021 and is projected to grow at a CAGR of 30.1% during the forecast period 2022-2032.

15 September 2022

READ